SYNLOGIC, INC.

Synlogic Inc. (SYBX) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the recent period. However, absence of near-term signals does not eliminate structural risks—particularly for clinical-stage biotech firms where financing events, equity dilution, and longer-term capital runway are critical drivers of shareholder value. The full $49 Report extends the analysis to 12 months of filings, quantifies dilution risk and cash-burn trajectory, maps financing history and planned raises, and flags emerging AI-related risk signals that may not yet appear in standard disclosures. The full $49 Report adds dilution-score trending, detailed 8-K context, capital structure analysis, and forward financing risk indicators.